Condition
Severe Dementia
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown2
Clinical Trials (2)
Showing 2 of 2 trials
NCT04347668Not ApplicableUnknown
Can Virtual Reality Reduce Depression and Agitation in Older Adults With Moderate to Severe Dementia?
NCT04321889Not ApplicableUnknownPrimary
Efficacy of Defurocumarinized Bergamot in the Treatment of Agitation in Severe Dementia Patients.
Showing all 2 trials